Daewoong Co., Ltd. (KOSE: A003090)
Health Care · Pharmaceuticals · KR
₩16,290.00
-10.05% today · -25.8% 1Y
Daewoong Co., Ltd. (KOSE: A003090) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $494.11M.
Over the last twelve months the share price has lost 25.8%, trading between 15.41K and 30.60K.
Tweenvest scores Daewoong Co., Ltd. across four factors: quality 75/100, value 72/100, growth 63/100, dividend 15/100. Its strongest factor is quality.
A003090 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $494.11M
- Revenue (TTM)
- $1.37B
- P/E
- 3.76
- EPS
- 4,328.21
- Dividend yield
- 1.23%
- Beta (5Y)
- 0.26
- 52-week high
- ₩30,600.00
- 52-week low
- ₩15,410.00
- Avg volume (3M)
- —
- Shares outstanding
- 42.04M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.